Parkinson's Test

SYNTap-CSF is the biomarker test for Parkinson’s disease. It allows doctors an accurate diagnosis of Parkinson’s on a molecular level.

What Is the SYNTap-CSF Test?

The Synuclein biomarker test detects misfolded Synuclein aggregates in Parkinson’s patients at all stages of the disease. A biomarker test using cerebral spinal fluid (CSF) offers the most accurate results in the development stages. 

How Does the SynTap Test Work:

Using a drop of CSF, our diagnostic test detects misfolded Synuclein’s presence, the prion-protein damaging the brain in Parkinson’s disease.

Learn more about the simple six-step process

Who Should Take This Test:

SYNTap-CSF helps doctors diagnose Parkinson’s disease for people who show:

  1. Early symptoms of a motor disorder that could be Parkinson’s or some other disease.
  2. Prodromal signs of Parkinson’s, including loss of taste and/or smell or severe sleep disorders.
  3. Signs of a progressive autonomic disorder include fainting spells, heart rate irregularities, constipation, and bladder control loss.

Since late-stage Parkinson’s can lead to a significant disability, including cognitive loss, it is critical to determine whether the patient has Parkinson’s as early as possible. 

The SYNTap biomarker test helps doctors make informed treatment choices that benefit the patient most. 

Learn more about the misfolded proteins and the role they play in Parkinson’s and other neurodegenerative diseases.

How Does SYNTap Test Benefit PD Patients?

The SynTap-CSF test benefits people in the early stages of Parkinson’s. These initial Parkinson’s stages are also called prodromal or early clinical stages of Parkinson’s disease. During these early stages, treatment options are more abundant and are likely to be most effective.

What Does A Negative Test Mean?

A negative test result means the absence of detectable Synuclein aggregates in the sample.

In plain speak, this negative SynTap-CSF test effectively rules out Parkinson’s disease even though the person shows clinical-stage motor symptoms.

It’s worth noting that for the people with prodromal Parkinson’s signs and a negative SYNTAP-CSF result, it is advisable to take the same test within 12 -24 months and repeat as necessary.

Like a routine check-up, this biomarker test is an excellent way to monitor the suspected bad actor’s on-going development in the brain. This information empowers your doctor to build an optimal brain health program specifically tailored for you.

Why Use CSF Instead of Blood?

Amprion’s research has demonstrated that CSF is the most reliable sample to detect prion-protein biomarkers in the brain in the early stage of Parkinson’s disease.

When misfolded Synuclein is detectable in the blood, it means the prion-proteins have replicated and amassed an army so large that they’ve breached the blood-brain barrier, traveling throughout the body via the bloodstream.

Benefit of CSF

To detect misfolded Synuclein in the brain at the early stages, the most accurate sample is cerebral spinal fluid (CSF).

scan of synuclein in diagnosis of Parkinson

GET THE SYNTap-CSF TEST

This biomarker test detects misfolded Synuclein, a prion-protein driving diseases such as Parkinson’s and Lewy Dementia, decades before symptoms. Sign up for email alerts on testing availability.

Blood Test For Parkinson's

In addition to our CSF test, we anticipate rolling out a blood test for misfolded Synuclein within the next 24-months. Sign up below to receive email alerts on testing availability.  

Who Benefits From the Blood Test?

The blood test will benefit people who have an increased risk of Parkinson’s due to genetic, environmental, and occupational risk factors. Through our blood test, your doctor can effectively monitor the development of misfolded Synuclein in the body, though at lower sensitivity than CSF.

Take the Parkinson's Blood Test

“I have no choice about whether or not I have Parkinson’s. I have nothing but choices about how I react to it. In those choices, there’s freedom to do a lot of things in areas that I wouldn’t have otherwise found myself in.”

Michael J. Fox

Michael J Fox-Parkinsons-800x800-1

“I have no choice about whether or not I have Parkinson’s. I have nothing but choices about how I react to it. In those choices, there’s freedom to do a lot of things in areas that I wouldn’t have otherwise found myself in.”

Michael J. Fox

Sign up for SYNTap-Blood Test

Get email alerts on testing availability.